Letybo (LetibotulinumtoxinA), a newly FDA-approved neuromodulator from Hugel, is making its way to U.S. medspas. With competitive pricing and proven efficacy, it offers a potential alternative to Botox and other treatments. Stay informed about its availability, benefits, and market positioning to determine if it’s right for your practice.